Sponsored by
Although this is for colon/ rectal cancer, we have to keep an eye on what is happening with all types of cancers. This article talks about specific mutations in colon cancer that make the tumor resistant to anti-EGFR therapy and some that actually make the tumor grow faster with anti-EGFR therapy.
As far as I know this has never been looked at with brain tumors. EGFR is a major target for us, and things like that have to be looked at.
to view the story, you need to register with medscape.. click: www.medscape.com/viewarticle/820934